PRECIRIX

Precirix is a private biotechnology company dedicated to extending and improving the lives of cancer patients by designing and developing novel radiopharmaceuticals, using camelid-derived single-domain antibodies (sdAb) labeled with radioisotopes.

Also known as: Precirix NV

Primary location: Brussels United States